Table 3 Hypertension prevalence as defined in ESH, AAP guidelines, and HNC standard stratified by demographic characteristics.
Explanatory variables | NHCC prevalence (95% CI) | ESH prevalence (95% CI) | AAP prevalence (95% CI) | Difference prevalence between NHCC and ESH (Da±SD) | Difference prevalence between NHCC and AAP (Da±SD) |
|---|---|---|---|---|---|
All participants | 11.73±(11.59, 11.86) | 10.04 (9.91, 10.16) | 15.75 (15.60, 15.91) | 1.69 ± 0.18 * | -4.03 ± 0.20* |
Age group | |||||
7–12 years | 10.65± (10.48,10.82) | 11.33 (11.16,11.50) | 16.71 (16.51,16.92) | -0.68 ± 0.24* | -6.06 ± 0.27* |
13–15 years | 13.30± (13.03,13.57) | 11.23 (10.98,11.48) | 12.78 (12.51,13.04) | 2.07 ± 0.38 * | 0.52 ± 0.37 * |
16–17 years | 13.03± (12.66,13.40) | 2.43 (2.26,2.60) | 17.63 (17.21,18.05) | 10.60 ± 0.40 * | -4.60 ± 0.56* |
Gender | |||||
Boys | 11.11± (10.93, 11.29) | 10.78± (10.60,10.97) | 17.78 (17.55, 18.00) | 0.33 ± 0.25 * | -6.99 ± 0.30 * |
Girls | 12.36± (12.17, 12.56) | 9.26± (9.08,9.43) | 13.65 (13.45, 13.86) | 3.11 ± 0.26* | -1.29 ± 0.28* |
Area | |||||
Urban | 10.19± (9.99,10.40) | 8.03± (7.84,8.21) | 14.03 (13.79,14.26) | 2.17 ± 0.28 * | -3.83 ± 0.31* |
Rural | 12.63± (12.45,12.80) | 11.22± (11.05,11.38) | 16.77 (16.57,16.97) | 1.41 ± 0.24 * | -4.14 ± 0.26* |
Region | |||||
Northern | 14.36± (14.04,14.68) | 13.43± (13.12,13.73) | 18.90 (18.55,19.25) | 0.94 ± 0.44 * | -4.54 ± 0.48* |
Central | 10.27± (10.10,10.44) | 8.42± (8.26,8.58) | 14.15 (13.95,14.35) | 1.85 ± 0.23 * | -3.88 ± 0.26* |
Southern | 12.71± (12.42,12.99) | 10.70± (10.44,10.97) | 16.62 (16.30,16.93) | 2.01 ± 0.39 * | -3.91 ± 0.43 * |
BMI status | |||||
Normal | 9.47± (9.33,9.62) | 7.83± (7.69,7.97) | 12.59 (12.42,12.76) | 1.64 ± 0.20 * | -3.12 ± 0.22 * |
Overweight | 13.99± (13.63,14.35) | 11.66± (11.33,11.99) | 18.64 (18.24,19.04) | 2.33 ± 0.48 * | -4.65 ± 0.54 * |
Obesity | 19.80± (19.37,20.24) | 18.61± (18.19,19.04) | 27.45 (26.96,27.93) | 1.19 ± 0.61* | -7.64 ± 0.65 * |